Search Results - "Burisch, Johan"

Knowledge and acceptability of the Lémann Index as a tool to measure disease progression and bowel damage in Crohn's disease: results from an international survey.

Authors: Wong, Charlotte Burisch, Johan Ungaro, Ryan C et al.

Source: Intestinal Research. Oct2025, Vol. 23 Issue 4, p512-523. 12p.

Equitable access to inflammatory bowel disease care: challenges, strategies, and future directions.

Authors: Burisch, Johan Banerjee, Rupa Watermeyer, Gillian

Source: Journal of Crohn's & Colitis. 2026 Supplement, Vol. 20, pii11-ii22. 12p.

ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease.

Authors: Gordon, Hannah Burisch, Johan Ellul, Pierre et al.

Source: Journal of Crohn's & Colitis. Jan2024, Vol. 18 Issue 1, p1-37. 37p.

Lack of Benefit for Early Escalation to Advanced Therapies in Ulcerative Colitis: Critical Appraisal of Current Evidence.

Authors: Burisch, Johan Safroneeva, Ekaterina Laoun, Raphael et al.

Source: Journal of Crohn's & Colitis. Dec2023, Vol. 17 Issue 12, p2002-2011. 10p.

Long‐term disease course, cost and prognosis of inflammatory bowel disease: epidemiological studies of a European and a Danish inception cohort.

Authors: Burisch, Johan¹ (AUTHOR) johan.burisch@regionh.dk

Source: APMIS. Jun2023 Supplement 1, Vol. 131, p1-46. 46p.

Iron deficiency should not be accepted in patients with inflammatory bowel disease – a Scandinavian expert opinion.

Authors: Detlie, Trond Espen Burisch, Johan Jahnsen, Jørgen et al.

Source: Scandinavian Journal of Gastroenterology. May2025, Vol. 60 Issue 5, p430-438. 9p.

Surgery, cancer and mortality among patients with ulcerative colitis diagnosed 1962‐1987 and followed until 2017 in a Danish population‐based inception cohort.

Authors: Burisch, Johan Lophaven, Søren Munkholm, Pia et al.

Source: Alimentary Pharmacology & Therapeutics. Feb2022, Vol. 55 Issue 3, p339-349. 11p. 4 Charts, 4 Graphs.

The clinical course of Crohn's disease in a Danish population‐based inception cohort with more than 50 years of follow‐up, 1962‐2017.

Authors: Burisch, Johan Lophaven, Søren Langholz, Ebbe et al.

Source: Alimentary Pharmacology & Therapeutics. Jan2022, Vol. 55 Issue 1, p73-82. 10p. 3 Charts, 4 Graphs.

Oral health in patients with inflammatory bowel disease: A cross-sectional survey in Sweden.

Authors: Bertl, Kristina Burisch, Johan Pandis, Nikolaos et al.

Source: Clinical Oral Investigations. Oct2024, Vol. 28 Issue 10, p1-17. 17p.

Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis.

Authors: Burisch, Johan Eigner, Wolfgang Schreiber, Stefan et al.

Source: PLoS ONE. 5/27/2020, Vol. 15 Issue 5, p1-15. 15p.

Viewpoint: Inflammatory Bowel Diseases Among Immigrants From Low- to High-Incidence Countries: Opportunities and Considerations.

Authors: Agrawal, Manasi Burisch, Johan Colombel, Jean-Frederic et al.

Source: Journal of Crohn's & Colitis. Feb2020, Vol. 14 Issue 2, p267-273. 7p.

Apples and oranges? Comparison of early ileocolic resection and medical treatment for Crohn's disease: a systematic review and meta-analysis.

Authors: Wewer, Mads Damsgaard Burisch, Johan Myrelid, Pär et al.

Source: Journal of Crohn's & Colitis. Nov2025, Vol. 19 Issue 11, p1-2. 2p.

Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort—An Epi-IBD Study.

Authors: Burisch, Johan Katsanos, Konstantinos H Christodoulou, Dimitrios K et al.

Source: Journal of Crohn's & Colitis. Feb2019, Vol. 13 Issue 2, p198-208. 11p.

IBD2020 global forum: results of an international patient survey on quality of care.

Authors: Irving, Peter Burisch, Johan Driscoll, Richard et al.

Source: Intestinal Research. Oct2018, Vol. 16 Issue 4, p537-545. 25p.

Validation of the 'United Registries for Clinical Assessment and Research' [UR-CARE], a European Online Registry for Clinical Care and Research in Inflammatory Bowel Disease.

Authors: Burisch, Johan Gisbert, Javier P. Siegmund, Britta et al.

Source: Journal of Crohn's & Colitis. May2018, Vol. 12 Issue 5, p532-537. 6p.

Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort--An ECCO-EpiCom Study.

Authors: Burisch, Johan Vegh, Zsuzsanna Katsanos, Konstantinnos H. et al.

Source: Journal of Crohn's & Colitis. Oct2017, Vol. 11 Issue 10, p1213-1222. 10p.

School of Medical Sciences, University of New South Wales, Sydney, NSW, Australia.

Authors: Burisch, Johan Ungaro, Ryan Vind, Ida et al.

Source: Journal of Crohn's & Colitis. Oct2017, Vol. 11 Issue 10, p1200-1204. 5p.

Editorial: Why are patients with Crohn's disease still treated with 5‐aminosalicylates?

Authors: Burisch, Johan^1,2 (AUTHOR) johan.burisch@regionh.dk

Source: Alimentary Pharmacology & Therapeutics. May2023, Vol. 57 Issue 9, p1044-1045. 2p.

Periodontitis prevalence in patients with ulcerative colitis and Crohn's disease ‐ PPCC: A case–control study.

Authors: Bertl, Kristina Burisch, Johan Pandis, Nikolaos et al.

Source: Journal of Clinical Periodontology. Dec2022, Vol. 49 Issue 12, p1262-1274. 13p. 6 Charts.

Impact of Anti-tumour Necrosis Factor Alpha Agents on the Risk of Colorectal Cancer.

Authors: Burisch, Johan^1,2 (AUTHOR) Johan.burisch@regionh.dk

Source: Journal of Crohn's & Colitis. Jun2022, Vol. 16 Issue 6, p871-872. 2p.